0000939767-24-000126.txt : 20240809
0000939767-24-000126.hdr.sgml : 20240809
20240809193219
ACCESSION NUMBER: 0000939767-24-000126
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240807
FILED AS OF DATE: 20240809
DATE AS OF CHANGE: 20240809
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aftab Dana
CENTRAL INDEX KEY: 0001959132
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30235
FILM NUMBER: 241194381
MAIL ADDRESS:
STREET 1: EXELIXIS, INC.
STREET 2: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXELIXIS, INC.
CENTRAL INDEX KEY: 0000939767
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 043257395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0103
BUSINESS ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
BUSINESS PHONE: 6508377000
MAIL ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS INC
DATE OF NAME CHANGE: 20000207
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20000106
4
1
wk-form4_1723246333.xml
FORM 4
X0508
4
2024-08-07
0
0000939767
EXELIXIS, INC.
EXEL
0001959132
Aftab Dana
C/O EXELIXIS, INC.
1851 HARBOR BAY PARKWAY
ALAMEDA
CA
94502
0
1
0
0
CSO/EVP Disc & Trans Research
1
Common Stock
2024-08-07
4
M
0
95000
24.41
A
615990
D
Common Stock
2024-08-07
4
S
0
95000
25
D
520990
D
Common Stock
5835
I
By 401(k)
Option (right to buy)
24.41
2024-08-07
4
M
0
95000
0
D
2018-10-03
2024-10-02
Common Stock
95000
0
D
Includes 288,932 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023.
Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of August 7, 2024.
The option, representing the right to purchase a total of 95,000 shares of Exelixis, Inc. common stock became fully exercisable on October 3, 2021.
/s/ Nina Ayer, Attorney in Fact
2024-08-09